Synectics Regulatory News (SNX)

22 Dec 2006 09:37

Synexus Clinical Research PLC22 December 2006 SYNEXUS CLINICAL RESEARCH PLCTOTAL VOTING RIGHTS AND CAPITAL In conformity with the Transparency Directive's transitional provision 6,Synexus Clinical Research plc (the "Company") would like to notify the marketthat the capital of the Company consists of 23,154,172 ordinary shares with anominal value of 10p each, with voting rights. The Company does not hold any ordinary shares in Treasury. Therefore, the total number of voting rights in the Company is 23,154,172 (the"Figure"). The Figure may be used by shareholders as the denominator for the calculationsby which they will determine if they are required to notify their interest in,or a change to their interest in the Company under the FSA's Disclosure andTransparency Rules. For further enquiries please contact the Chief Financial Officer: Paul McCluskey (01257 230723) Ends This information is provided by RNS The company news service from the London Stock Exchange